"Das Klinikum Leverkusen ist ein Krankenhaus der regionalen Spitzenversorgung mit Einrichtungen für hochqualifizierte Diagnostik und Therapie. Mehr als 2.400 Menschen kümmern sich in 12 medizinischen Fachabteilungen, zahlreichen Zentren und Instituten sowie in den Servicebereichen, Tochtergesellschaften und in der Verwaltung um die Gesundheit und das Wohlbefinden unserer Patientinnen und Patienten. Ärzte, Apotheker, Pflegekräfte, Therapeuten und andere Berufsgruppen sind dafür rund um die Uhr im Einsatz."

During the past decade, Klinikum Leverkusen conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Leverkusen" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Antisoma Research" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Dominik Paul Modest" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Leverkusen" #1 collaborator was "Averion International Corporation" with 1 trials as a collaborator, "ClinStat GmbH" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ferrer Internacional S.A." with 1 trials as a collaborator and "German Research Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Leverkusen" are "Heart Failure" (4 trials), "Acute Myocardial Infarction" (1 trials), "Atrial Arrhythmia" (1 trials), "Atrial Fibrillation" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Klinikum Leverkusen" in a lesser frequency.

Most popular intervention types in "Klinikum Leverkusen" are "Drug" (11 trials), "Device" (5 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acalabrutinib" (1 trials), "Amonafide and Cytarabine" (1 trials), "Angioplasty (PROMUS Element™, and Xience™ Prime stent)" (1 trials) and "Apabetalone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Leverkusen" are 19 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Leverkusen". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Klinikum Leverkusen, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Leverkusen, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Klinikum Leverkusen has several departments that took part in Clinical trials: "Klinikum Leverkusen; Med. Klinik III / Onkologie" - 5 trials